CytoDyn Inc.(CYDY)- OTCQB
Company Description
CytoDyn is a publicly traded biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses. CytoDyn's lead product candidate, PRO 140, has the potential to drive groundbreaking advancements in developing the next generation of HIV... More
Sector: Healthcare
Industry: Biotechnology
Country: United States